ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 101 filers reported holding ADICET BIO INC in Q4 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,638 | -44.3% | 46,458 | -1.2% | 0.00% | – |
| Q2 2023 | $114,261 | +41601.1% | 47,021 | -1.3% | 0.00% | – |
| Q1 2023 | $274 | -32.5% | 47,618 | +4.9% | 0.00% | -100.0% |
| Q4 2022 | $406 | -99.9% | 45,375 | +6.1% | 0.00% | 0.0% |
| Q3 2022 | $608,000 | +4.1% | 42,769 | +6.9% | 0.00% | 0.0% |
| Q2 2022 | $584,000 | -7.7% | 40,001 | +26.3% | 0.00% | 0.0% |
| Q1 2022 | $633,000 | +60.7% | 31,679 | +40.7% | 0.00% | – |
| Q4 2021 | $394,000 | +141.7% | 22,519 | +8.2% | 0.00% | – |
| Q3 2021 | $163,000 | -21.6% | 20,816 | +2.8% | 0.00% | – |
| Q2 2021 | $208,000 | – | 20,253 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
| Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
| DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
| COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
| JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
| Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
| Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
| Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |